This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
#GivingTuesday is a global day of giving fueled by the power of social media and collaboration.
CRI Fellow Timothy Fessenden, Ph.D., will share a day in the life of a scientist on the Cancer Research Institute Twitter account.
On Friday, June 12, 2020, we invite you to wear white for a future immune to cancer, raising awareness of the lifesaving potential of immunotherapy.
Join us for the 8th Annual Cancer Immunotherapy Month™ in June hosted by the Cancer Research Institute.
#GivingTuesdayNow is a global day of giving and unity that will take place on May 5, 2020 as an emergency response to the unprecedented need caused by COVID-19.
On February 4, join the global awareness campaign to support cancer prevention and lifesaving treatments.
On Friday, June 14, 2019, we invite you to wear white for a future immune to cancer, raising awareness of the lifesaving potential of immunotherapy, as part of the 7th Annual Cancer Immunotherapy Month.
Cancer Research Institute will host a Twitter Chat titled "Cancer Immunotherapy Insights from ASCO" and moderated by Sharon Begley (@sxbegle), senior science writer at STAT. on the hashtag #CIMchat.
Join us for the 7th Annual Cancer Immunotherapy Month™ in June hosted by the Cancer Research Institute.
CRI.ContactUs
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.
Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.